Proficio Capital Partners’s Finch Therapeutics Group, Inc. Common Stock FNCH Stock Holding History

Proficio Capital Partners’s Portfolio FNCH Stock Details FNCH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,685	Closed	-$43.5K	–	317
2023 Q1	$43.5K	Hold	3,685	–	–	0.01%	280
2022 Q4	$53.1K	Hold	3,685	–	–	0.01%	278
2022 Q3	$185K	Hold	3,685	–	–	0.03%	251
2022 Q2	$314K	Hold	3,685	–	–	0.06%	183
2022 Q1	$556K	Hold	3,685	–	–	0.08%	123
2021 Q4	$1.1M	Hold	3,685	–	–	0.15%	91
2021 Q3	$1.44M	Sell	3,685 -50	-1%	-$21.3K	0.19%	81
2021 Q2	$1.58M	Buy	3,735 +16	+0.4%	+$6.92K	0.19%	75
2021 Q1	$1.8M	Buy	+3,719	New	+$1.89M	0.23%	63

Other funds holding FNCH

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

AMC

Avenir Management Company New York $43.8M AUM 101.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LSAG

Lake Street Advisors Group Portsmouth, New Hampshire $2.17B AUM 16.99% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Proficio Capital Partners's FNCH Position: Q2 2023 in Review

Proficio Capital Partners sold out of Finch Therapeutics Group, Inc. Common Stock (FNCH) in Q2 2023, closing a stake of 3,685 shares — an estimated $43.5K sold.

Proficio Capital Partners first reported a position in FNCH in Q1 2021 and held it in 9 quarters. The position peaked at $1.8M in Q1 2021. 17 funds tracked by Wall St. Rank hold FNCH as of Q2 2023.

Proficio Capital Partners reported no remaining Finch Therapeutics Group, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Proficio Capital Partners sold 3,685 Finch Therapeutics Group, Inc. Common Stock shares in Q2 2023, an estimated $43.5K.
Proficio Capital Partners first reported a position in Finch Therapeutics Group, Inc. Common Stock in Q1 2021 and held it in 9 quarters.
Proficio Capital Partners's Finch Therapeutics Group, Inc. Common Stock position peaked at $1.8M in Q1 2021.
17 funds tracked by Wall St. Rank held Finch Therapeutics Group, Inc. Common Stock as of Q2 2023.

Based on Proficio Capital Partners's 13F filing for Q2 2023, filed 14 Aug 2023.